ERBB2 and breast cancer: Three selective SERT antagonists (sertraline, fluoxetine, and paroxetine) identified in the screen reduced the frequency of sphere-forming cells in a dose-dependent fashion in multiple independent tumorsphere cultures derived from MMTV-Neu mammary tumors of independent mice, suggesting that they targeted BTIC [22].